WallStreetZenWallStreetZen

NASDAQ: PGNY
Progyny Inc Stock

$34.21+0.96 (+2.89%)
Updated Sep 26, 2023
PGNY Price
$34.21
Fair Value Price
$35.76
Market Cap
$3.26B
52 Week Low
$28.03
52 Week High
$45.98
P/E
64.55x
P/B
6.95x
P/S
3.89x
PEG
N/A
Dividend Yield
N/A
Revenue
$957.46M
Earnings
$49.29M
Gross Margin
21.9%
Operating Margin
4.9%
Profit Margin
5.1%
Debt to Equity
0.45
Operating Cash Flow
$169M
Beta
1.4
Next Earnings
Nov 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A

PGNY Overview

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PGNY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PGNY ($34.21) is undervalued by 4.34% relative to our estimate of its Fair Value price of $35.76 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PGNY ($34.21) is not significantly undervalued (4.34%) relative to our estimate of its Fair Value price of $35.76 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PGNY is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PGNY due diligence checks available for Premium users.

Be the first to know about important PGNY news, forecast changes, insider trades & much more!

PGNY News

Valuation

PGNY fair value

Fair Value of PGNY stock based on Discounted Cash Flow (DCF)
Price
$34.21
Fair Value
$35.76
Undervalued by
4.34%
PGNY ($34.21) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PGNY ($34.21) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PGNY is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PGNY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
64.55x
Industry
55.14x
Market
14.06x
PGNY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PGNY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

PGNY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.95x
Industry
3.07x
PGNY is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PGNY's financial health

Profit margin

Revenue
$279.4M
Net Income
$15.0M
Profit Margin
5.4%
PGNY's Earnings (EBIT) of $46.89M... subscribe to Premium to read more.
Interest Coverage Financials
PGNY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$681.5M
Liabilities
$212.0M
Debt to equity
0.45
PGNY's short-term assets ($561.13M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PGNY's short-term assets ($561.13M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PGNY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$76.0M
Investing
-$58.9M
Financing
-$1.8M
PGNY's operating cash flow ($169.38M)... subscribe to Premium to read more.
Debt Coverage Financials

PGNY vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
PGNY$3.26B+2.89%64.55x6.95x
TDOC$3.14B-0.26%-0.77x1.37x
EVH$3.04B-0.07%-38.30x2.78x
DOCS$3.87B-1.49%32.56x3.90x
PINC$2.59B+0.55%14.81x1.11x

Progyny Stock FAQ

What is Progyny's quote symbol?

(NASDAQ: PGNY) Progyny trades on the NASDAQ under the ticker symbol PGNY. Progyny stock quotes can also be displayed as NASDAQ: PGNY.

If you're new to stock investing, here's how to buy Progyny stock.

What is the 52 week high and low for Progyny (NASDAQ: PGNY)?

(NASDAQ: PGNY) Progyny's 52-week high was $45.98, and its 52-week low was $28.03. It is currently -25.6% from its 52-week high and 22.05% from its 52-week low.

How much is Progyny stock worth today?

(NASDAQ: PGNY) Progyny currently has 95,406,381 outstanding shares. With Progyny stock trading at $34.21 per share, the total value of Progyny stock (market capitalization) is $3.26B.

Progyny stock was originally listed at a price of $15.94 in Oct 25, 2019. If you had invested in Progyny stock at $15.94, your return over the last 3 years would have been 114.62%, for an annualized return of 28.99% (not including any dividends or dividend reinvestments).

How much is Progyny's stock price per share?

(NASDAQ: PGNY) Progyny stock price per share is $34.21 today (as of Sep 26, 2023).

What is Progyny's Market Cap?

(NASDAQ: PGNY) Progyny's market cap is $3.26B, as of Sep 27, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Progyny's market cap is calculated by multiplying PGNY's current stock price of $34.21 by PGNY's total outstanding shares of 95,406,381.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.